W. Queißer

2.1k total citations
111 papers, 1.4k citations indexed

About

W. Queißer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, W. Queißer has authored 111 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 26 papers in Hematology. Recurrent topics in W. Queißer's work include Colorectal Cancer Treatments and Studies (23 papers), Cancer Treatment and Pharmacology (17 papers) and Gastric Cancer Management and Outcomes (15 papers). W. Queißer is often cited by papers focused on Colorectal Cancer Treatments and Studies (23 papers), Cancer Treatment and Pharmacology (17 papers) and Gastric Cancer Management and Outcomes (15 papers). W. Queißer collaborates with scholars based in Germany, Switzerland and United States. W. Queißer's co-authors include H. Heimpel, Rüdiger Hehlmann, Joerg Hasford, H. Pralle, H. Löffler, B Heinze, HJ Kolb, DK Hossfeld, Andreas Hochhaus and Lutz Edler and has published in prestigious journals such as Blood, Annals of Oncology and Marine Ecology Progress Series.

In The Last Decade

W. Queißer

103 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
W. Queißer 729 545 375 270 215 111 1.4k
Robert E. Rydell 1.1k 1.5× 484 0.9× 278 0.7× 97 0.4× 380 1.8× 27 1.8k
Tariq I. Mughal 888 1.2× 788 1.4× 430 1.1× 353 1.3× 463 2.2× 115 1.7k
Canellos Gp 516 0.7× 412 0.8× 361 1.0× 126 0.5× 116 0.5× 49 1.3k
Saengsuree Jootar 1.2k 1.6× 915 1.7× 199 0.5× 514 1.9× 144 0.7× 75 1.5k
Francesc Cobo 352 0.5× 650 1.2× 367 1.0× 131 0.5× 266 1.2× 38 1.2k
Rolf Billström 1.2k 1.7× 473 0.9× 185 0.5× 156 0.6× 538 2.5× 58 1.7k
Mark Shapiro 351 0.5× 317 0.6× 471 1.3× 128 0.5× 157 0.7× 49 1.4k
Gareth Gerrard 1.3k 1.8× 984 1.8× 399 1.1× 478 1.8× 505 2.3× 75 2.2k
Maud Janvier 918 1.3× 483 0.9× 597 1.6× 66 0.2× 500 2.3× 48 1.6k
Hans Grünwald 789 1.1× 338 0.6× 403 1.1× 55 0.2× 365 1.7× 52 1.4k

Countries citing papers authored by W. Queißer

Since Specialization
Citations

This map shows the geographic impact of W. Queißer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Queißer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Queißer more than expected).

Fields of papers citing papers by W. Queißer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Queißer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Queißer. The network helps show where W. Queißer may publish in the future.

Co-authorship network of co-authors of W. Queißer

This figure shows the co-authorship network connecting the top 25 collaborators of W. Queißer. A scholar is included among the top collaborators of W. Queißer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Queißer. W. Queißer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manegold, C., P. Drings, U. Gatzemeier, et al.. (1996). Lobaplatin (D-19466) in Patients with Advanced Non-Small-Cell Lung Cancer: A Trial of the Association for Medical Oncology (AIO) Phase II Study Group. Oncology Research and Treatment. 19(3). 248–251. 7 indexed citations
2.
Hartung, G., W. Queißer, E. Hagmüller, et al.. (1996). Adjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in Colorectal Cancer: Evaluation of Toxicity. Oncology Research and Treatment. 19(1). 62–67. 4 indexed citations
3.
Queißer, W., et al.. (1996). Long-Term Stabilization in a Patient with Nonresected Pancreatic Carcinoma Undergoing Chemotherapy. Oncology Research and Treatment. 19(4). 337–339. 2 indexed citations
4.
Herrmann, Richard, K. Mross, Ulrich R. Kleeberg, et al.. (1995). 4′-lodo-4′-Deoxydoxorubicin (IDX) in Colorectal Cancer – A Multicenter Phase II Study. Oncology Research and Treatment. 18(1). 28–30. 1 indexed citations
5.
Hartung, G., D. Jentschura, M. Trede, & W. Queißer. (1995). Effective Secondary Neoadjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in a Patient with Cancer of the Colon. Oncology Research and Treatment. 18(2). 142–144. 2 indexed citations
6.
Heim, Manfred, W. Queißer, Martin Pecherstorfer, et al.. (1995). Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study. Oncology Research and Treatment. 18(5). 439–448. 37 indexed citations
7.
Schröder, M. & W. Queißer. (1994). Management of Desmoid Tumours. Oncology Research and Treatment. 17(4). 376–380. 8 indexed citations
8.
Huber, H., et al.. (1993). Impressum, Vol. 13, No. 4, 1993. Oncology Research and Treatment. 16(4). 217–217. 4 indexed citations
9.
Bokemeyer, Carsten, Jean‐Pierre Droz, Axel‐R. Hanauske, et al.. (1993). Treatment of Relapsed Nonseminomatous Germ Cell Tumors with Vinorelbine: A Trial of the Phase 1/11 Study Group of the Association for Medical Oncology of the German Cancer Society. Oncology Research and Treatment. 16(1). 29–31. 14 indexed citations
10.
Hartung, G., et al.. (1993). New Approaches to Adjuvant Therapy of Colorectal Carcinoma Including Current German Activities. Oncology Research and Treatment. 16(6). 416–424. 2 indexed citations
11.
Baldus, M., et al.. (1992). Spontaneous Remission of Chronic Lymphocytic Leukemia A Casuistic Contribution. Oncology Research and Treatment. 15(6). 506–510.
12.
Queißer, W., et al.. (1991). Phase II Study of Vinorelbine by Oral Route (in a Hard Gelatine Capsule) for Metastatic Breast Cancer Patients. Oncology Research and Treatment. 14(1). 35–39. 6 indexed citations
13.
Heim, Manfred, et al.. (1991). Prospective Multicenter Phase-Ill Trial of Doxifluridine (5’dFUR) versus 5-Fluorouracil in Patients with Advanced Colorectal Carcinoma. Oncology Research and Treatment. 14(4). 333–337. 2 indexed citations
14.
Queißer, W., P. Preusser, K. Mross, et al.. (1990). Phase II Evaluation of Carboplatin in Advanced Esophageal Carcinoma. Oncology Research and Treatment. 13(3). 190–193. 9 indexed citations
15.
Kurrle, E., Gerhard Ehninger, Mathias Freund, et al.. (1988). A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Annals of Hematology. 56(5). 233–236. 9 indexed citations
16.
Flechtner, Hans‐Henning, W. Queißer, Manfred Heim, et al.. (1987). 5-Fluorouracil, 4-Epidoxorubicin, and Mitomycin C (FEM) Combination Chemotherapy for Advanced Gastric Carcinoma. A Phase-II Trial by the “Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)”. Oncology Research and Treatment. 10(2). 67–71. 5 indexed citations
17.
Queißer, W., Helmut König, Dieter Fritze, et al.. (1986). Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer.. PubMed. 70(4). 477–9. 19 indexed citations
18.
Queißer, W. & Hans‐Henning Flechtner. (1986). Chemotherapy of Advanced Gastric Carcinoma. Oncology Research and Treatment. 9(6). 319–331. 2 indexed citations
19.
20.
Mayer, M, et al.. (1977). Proliferation characteristics of erythroblasts in chronic renal failure. Annals of Hematology. 35(1). 45–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Rydell Breakdown of academic impact, for papers by Tariq I. Mughal Breakdown of academic impact, for papers by Canellos Gp Breakdown of academic impact, for papers by Saengsuree Jootar Breakdown of academic impact, for papers by Francesc Cobo Breakdown of academic impact, for papers by Rolf Billström Breakdown of academic impact, for papers by Mark Shapiro Breakdown of academic impact, for papers by Gareth Gerrard Breakdown of academic impact, for papers by Maud Janvier Breakdown of academic impact, for papers by Hans Grünwald
Rankless by CCL
2026